Bill Cole Mayor at City of Billings | Facebook Website
Bill Cole Mayor at City of Billings | Facebook Website
RiverStone Health, along with the Montana Department of Public Health and Human Services (DPHHS), has confirmed the first influenza-related deaths in Yellowstone County for the 2024-2025 season. The deceased include a man in his 50s, a woman in her 80s, and a man in his 60s, all of whom died last week in hospitals located in Billings.
Across Montana, there have been 2,015 reported flu cases this season, leading to 115 hospitalizations and nine deaths. Specifically in Yellowstone County, since October 5th, there have been 374 reported cases.
Dr. Megan Littlefield, RiverStone Health's Chief Medical Officer, emphasized the seriousness of influenza despite its commonality: “Although it feels common, influenza remains a serious infection that can unfortunately be deadly.” She stressed the importance of taking precautions to protect vulnerable populations from illness.
Hospitalization rates for respiratory illnesses like flu and COVID-19 are rising both locally and nationally. Vaccination is highlighted as the best defense against influenza and its severe complications. Flu and COVID-19 vaccines are accessible through various local health facilities including RiverStone Health Immunization Clinic and other medical offices.
Influenza is spread via coughing and sneezing with symptoms such as high fever, chills, headaches, exhaustion, sore throat, coughs, and body aches appearing between one to four days after exposure. People may be contagious from one day before symptoms appear up to five to seven days afterward.
To prevent spreading influenza, recommended measures include getting vaccinated; wearing masks or using tissues when coughing or sneezing; frequent hand washing; avoiding touching one's face; staying away from sick individuals; and remaining at home for at least 24 hours after fever subsides unless seeking medical care or necessities.
For those infected with influenza, antiviral medications like Tamiflu can lessen symptoms if administered within two days of onset. These medications are particularly advised for children under two years old, adults over 65 years old, and individuals with chronic health conditions.